Antiviral Activity of Ergoferon against Group A Rotavirus
- Авторы: Emelianova A.G.1, Shilovskii I.P.2, Sundukova M.S.2, Khaitov M.R.2, Epshtein O.I.1
- 
							Учреждения: 
							- Laboratory of Physiologically Active Substances, Department of Molecular and Cellular Pathology and Pathophysiology, Research Institute of General Pathology and Pathophysiology
- State Research Center Institute of Immunology, Federal Medical-Biological Agency
 
- Выпуск: Том 161, № 6 (2016)
- Страницы: 806-807
- Раздел: Virology
- URL: https://journals.rcsi.science/0007-4888/article/view/237801
- DOI: https://doi.org/10.1007/s10517-016-3516-x
- ID: 237801
Цитировать
Аннотация
Antiviral activity of Ergoferon was studied in vitro on an experimental model of rotavirus infection in MA-104 cell line. In infected cells treated with Ergoferon, rotavirus titer was shown to decrease by 83 and 90% in comparison with cells treated with solvent used for Ergoferon preparation (p<0.05) and distilled water (p<0.05), respectively. These findings demonstrate high anti-rotavirus activity of Ergoferon.
Об авторах
A. Emelianova
Laboratory of Physiologically Active Substances, Department of Molecular and Cellular Pathology and Pathophysiology, Research Institute of General Pathology and Pathophysiology
							Автор, ответственный за переписку.
							Email: agemelianova@gmail.com
				                					                																			                												                	Россия, 							Moscow						
I. Shilovskii
State Research Center Institute of Immunology, Federal Medical-Biological Agency
														Email: agemelianova@gmail.com
				                					                																			                												                	Россия, 							Moscow						
M. Sundukova
State Research Center Institute of Immunology, Federal Medical-Biological Agency
														Email: agemelianova@gmail.com
				                					                																			                												                	Россия, 							Moscow						
M. Khaitov
State Research Center Institute of Immunology, Federal Medical-Biological Agency
														Email: agemelianova@gmail.com
				                					                																			                												                	Россия, 							Moscow						
O. Epshtein
Laboratory of Physiologically Active Substances, Department of Molecular and Cellular Pathology and Pathophysiology, Research Institute of General Pathology and Pathophysiology
														Email: agemelianova@gmail.com
				                					                																			                												                	Россия, 							Moscow						
Дополнительные файлы
 
				
			 
						 
					 
						 
						 
						 
									 
  
  
  
  
  Отправить статью по E-mail
			Отправить статью по E-mail  Открытый доступ
		                                Открытый доступ Доступ предоставлен
						Доступ предоставлен Только для подписчиков
		                                		                                        Только для подписчиков
		                                					